IBDEI2ZV ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,47818,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47818,1,3,0)
;;=3^Lupus Erythematosus,Subacute Cutaneous
;;^UTILITY(U,$J,358.3,47818,1,4,0)
;;=4^L93.1
;;^UTILITY(U,$J,358.3,47818,2)
;;=^5009468
;;^UTILITY(U,$J,358.3,47819,0)
;;=L93.2^^185^2412^54
;;^UTILITY(U,$J,358.3,47819,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47819,1,3,0)
;;=3^Lupus Erythematosus,Other
;;^UTILITY(U,$J,358.3,47819,1,4,0)
;;=4^L93.2
;;^UTILITY(U,$J,358.3,47819,2)
;;=^5009469
;;^UTILITY(U,$J,358.3,47820,0)
;;=L04.9^^185^2412^59
;;^UTILITY(U,$J,358.3,47820,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47820,1,3,0)
;;=3^Lymphadenitis,Acute,Unspec
;;^UTILITY(U,$J,358.3,47820,1,4,0)
;;=4^L04.9
;;^UTILITY(U,$J,358.3,47820,2)
;;=^5009074
;;^UTILITY(U,$J,358.3,47821,0)
;;=R59.1^^185^2412^56
;;^UTILITY(U,$J,358.3,47821,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47821,1,3,0)
;;=3^Lymph Nodes,Enlarged,Generalized
;;^UTILITY(U,$J,358.3,47821,1,4,0)
;;=4^R59.1
;;^UTILITY(U,$J,358.3,47821,2)
;;=^5019530
;;^UTILITY(U,$J,358.3,47822,0)
;;=R59.0^^185^2412^57
;;^UTILITY(U,$J,358.3,47822,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47822,1,3,0)
;;=3^Lymph Nodes,Enlarged,Localized
;;^UTILITY(U,$J,358.3,47822,1,4,0)
;;=4^R59.0
;;^UTILITY(U,$J,358.3,47822,2)
;;=^5019529
;;^UTILITY(U,$J,358.3,47823,0)
;;=R59.9^^185^2412^58
;;^UTILITY(U,$J,358.3,47823,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47823,1,3,0)
;;=3^Lymph Nodes,Enlarged,Unspec
;;^UTILITY(U,$J,358.3,47823,1,4,0)
;;=4^R59.9
;;^UTILITY(U,$J,358.3,47823,2)
;;=^5019531
;;^UTILITY(U,$J,358.3,47824,0)
;;=L60.9^^185^2412^61
;;^UTILITY(U,$J,358.3,47824,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47824,1,3,0)
;;=3^Nail Disorder,Unspec
;;^UTILITY(U,$J,358.3,47824,1,4,0)
;;=4^L60.9
;;^UTILITY(U,$J,358.3,47824,2)
;;=^5009240
;;^UTILITY(U,$J,358.3,47825,0)
;;=L60.3^^185^2412^62
;;^UTILITY(U,$J,358.3,47825,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47825,1,3,0)
;;=3^Nail Dystrophy
;;^UTILITY(U,$J,358.3,47825,1,4,0)
;;=4^L60.3
;;^UTILITY(U,$J,358.3,47825,2)
;;=^5009236
;;^UTILITY(U,$J,358.3,47826,0)
;;=L60.0^^185^2412^63
;;^UTILITY(U,$J,358.3,47826,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47826,1,3,0)
;;=3^Nail,Ingrowing
;;^UTILITY(U,$J,358.3,47826,1,4,0)
;;=4^L60.0
;;^UTILITY(U,$J,358.3,47826,2)
;;=^5009234
;;^UTILITY(U,$J,358.3,47827,0)
;;=L60.2^^185^2412^70
;;^UTILITY(U,$J,358.3,47827,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47827,1,3,0)
;;=3^Onychogryphosis
;;^UTILITY(U,$J,358.3,47827,1,4,0)
;;=4^L60.2
;;^UTILITY(U,$J,358.3,47827,2)
;;=^5009235
;;^UTILITY(U,$J,358.3,47828,0)
;;=L97.109^^185^2412^69
;;^UTILITY(U,$J,358.3,47828,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47828,1,3,0)
;;=3^Nonpressure Chr Ulcer of Thigh
;;^UTILITY(U,$J,358.3,47828,1,4,0)
;;=4^L97.109
;;^UTILITY(U,$J,358.3,47828,2)
;;=^5009484
;;^UTILITY(U,$J,358.3,47829,0)
;;=L97.209^^185^2412^65
;;^UTILITY(U,$J,358.3,47829,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47829,1,3,0)
;;=3^Nonpressure Chr Ulcer of Calf
;;^UTILITY(U,$J,358.3,47829,1,4,0)
;;=4^L97.209
;;^UTILITY(U,$J,358.3,47829,2)
;;=^5009499
;;^UTILITY(U,$J,358.3,47830,0)
;;=L97.309^^185^2412^64
;;^UTILITY(U,$J,358.3,47830,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47830,1,3,0)
;;=3^Nonpressure Chr Ulcer of Ankle
;;^UTILITY(U,$J,358.3,47830,1,4,0)
;;=4^L97.309
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2ZV 3783 printed Oct 16, 2024@18:39:50 Page 2
IBDEI2ZV ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,47818,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,47818,1,3,0)
+4 ;;=3^Lupus Erythematosus,Subacute Cutaneous
+5 ;;^UTILITY(U,$J,358.3,47818,1,4,0)
+6 ;;=4^L93.1
+7 ;;^UTILITY(U,$J,358.3,47818,2)
+8 ;;=^5009468
+9 ;;^UTILITY(U,$J,358.3,47819,0)
+10 ;;=L93.2^^185^2412^54
+11 ;;^UTILITY(U,$J,358.3,47819,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,47819,1,3,0)
+14 ;;=3^Lupus Erythematosus,Other
+15 ;;^UTILITY(U,$J,358.3,47819,1,4,0)
+16 ;;=4^L93.2
+17 ;;^UTILITY(U,$J,358.3,47819,2)
+18 ;;=^5009469
+19 ;;^UTILITY(U,$J,358.3,47820,0)
+20 ;;=L04.9^^185^2412^59
+21 ;;^UTILITY(U,$J,358.3,47820,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,47820,1,3,0)
+24 ;;=3^Lymphadenitis,Acute,Unspec
+25 ;;^UTILITY(U,$J,358.3,47820,1,4,0)
+26 ;;=4^L04.9
+27 ;;^UTILITY(U,$J,358.3,47820,2)
+28 ;;=^5009074
+29 ;;^UTILITY(U,$J,358.3,47821,0)
+30 ;;=R59.1^^185^2412^56
+31 ;;^UTILITY(U,$J,358.3,47821,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,47821,1,3,0)
+34 ;;=3^Lymph Nodes,Enlarged,Generalized
+35 ;;^UTILITY(U,$J,358.3,47821,1,4,0)
+36 ;;=4^R59.1
+37 ;;^UTILITY(U,$J,358.3,47821,2)
+38 ;;=^5019530
+39 ;;^UTILITY(U,$J,358.3,47822,0)
+40 ;;=R59.0^^185^2412^57
+41 ;;^UTILITY(U,$J,358.3,47822,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,47822,1,3,0)
+44 ;;=3^Lymph Nodes,Enlarged,Localized
+45 ;;^UTILITY(U,$J,358.3,47822,1,4,0)
+46 ;;=4^R59.0
+47 ;;^UTILITY(U,$J,358.3,47822,2)
+48 ;;=^5019529
+49 ;;^UTILITY(U,$J,358.3,47823,0)
+50 ;;=R59.9^^185^2412^58
+51 ;;^UTILITY(U,$J,358.3,47823,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,47823,1,3,0)
+54 ;;=3^Lymph Nodes,Enlarged,Unspec
+55 ;;^UTILITY(U,$J,358.3,47823,1,4,0)
+56 ;;=4^R59.9
+57 ;;^UTILITY(U,$J,358.3,47823,2)
+58 ;;=^5019531
+59 ;;^UTILITY(U,$J,358.3,47824,0)
+60 ;;=L60.9^^185^2412^61
+61 ;;^UTILITY(U,$J,358.3,47824,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,47824,1,3,0)
+64 ;;=3^Nail Disorder,Unspec
+65 ;;^UTILITY(U,$J,358.3,47824,1,4,0)
+66 ;;=4^L60.9
+67 ;;^UTILITY(U,$J,358.3,47824,2)
+68 ;;=^5009240
+69 ;;^UTILITY(U,$J,358.3,47825,0)
+70 ;;=L60.3^^185^2412^62
+71 ;;^UTILITY(U,$J,358.3,47825,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,47825,1,3,0)
+74 ;;=3^Nail Dystrophy
+75 ;;^UTILITY(U,$J,358.3,47825,1,4,0)
+76 ;;=4^L60.3
+77 ;;^UTILITY(U,$J,358.3,47825,2)
+78 ;;=^5009236
+79 ;;^UTILITY(U,$J,358.3,47826,0)
+80 ;;=L60.0^^185^2412^63
+81 ;;^UTILITY(U,$J,358.3,47826,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,47826,1,3,0)
+84 ;;=3^Nail,Ingrowing
+85 ;;^UTILITY(U,$J,358.3,47826,1,4,0)
+86 ;;=4^L60.0
+87 ;;^UTILITY(U,$J,358.3,47826,2)
+88 ;;=^5009234
+89 ;;^UTILITY(U,$J,358.3,47827,0)
+90 ;;=L60.2^^185^2412^70
+91 ;;^UTILITY(U,$J,358.3,47827,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,47827,1,3,0)
+94 ;;=3^Onychogryphosis
+95 ;;^UTILITY(U,$J,358.3,47827,1,4,0)
+96 ;;=4^L60.2
+97 ;;^UTILITY(U,$J,358.3,47827,2)
+98 ;;=^5009235
+99 ;;^UTILITY(U,$J,358.3,47828,0)
+100 ;;=L97.109^^185^2412^69
+101 ;;^UTILITY(U,$J,358.3,47828,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,47828,1,3,0)
+104 ;;=3^Nonpressure Chr Ulcer of Thigh
+105 ;;^UTILITY(U,$J,358.3,47828,1,4,0)
+106 ;;=4^L97.109
+107 ;;^UTILITY(U,$J,358.3,47828,2)
+108 ;;=^5009484
+109 ;;^UTILITY(U,$J,358.3,47829,0)
+110 ;;=L97.209^^185^2412^65
+111 ;;^UTILITY(U,$J,358.3,47829,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,47829,1,3,0)
+114 ;;=3^Nonpressure Chr Ulcer of Calf
+115 ;;^UTILITY(U,$J,358.3,47829,1,4,0)
+116 ;;=4^L97.209
+117 ;;^UTILITY(U,$J,358.3,47829,2)
+118 ;;=^5009499
+119 ;;^UTILITY(U,$J,358.3,47830,0)
+120 ;;=L97.309^^185^2412^64
+121 ;;^UTILITY(U,$J,358.3,47830,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,47830,1,3,0)
+124 ;;=3^Nonpressure Chr Ulcer of Ankle
+125 ;;^UTILITY(U,$J,358.3,47830,1,4,0)
+126 ;;=4^L97.309
